2023-07-24 13:58:17 ET
- Baxter International ( NYSE: BAX ) has announced the launch of PERCLOT Absorbable Hemostatic Powder in the U.S.
- PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding.
- To coincide with the launch of PERCLOT in the U.S., Baxter is working closely with key customers representing multiple leading hospitals across the country to add PERCLOT to their standard of care for low level bleeds..
- “The launch of PERCLOT in the U.S. allows us to provide surgeons with a full range of active and passive hemostatic products for bleeding control, helping to optimize care for their patients.” said Steve Wallace, President, Advanced Surgery at Baxter.
For further details see:
Baxter launches PERCLOT Absorbable Hemostatic Powder